Episode 248: Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more

248.png

Drs. Ferhina Ali and Daniel Chao join for a journal club discussion of the following articles:

Relevant Financial Disclosures:
Dr. Sridhar is a consultant for Alcon, Regeneron, and Oxurion. Dr. Ali is a consultant for Genentech and Voyant Biotherapeutics. Dr. Chao is a consultant for Recens Medical, DTXPharma, Allergan, Visgenx, and Zilia and receives research funding from the National Eye Institute, Bright Focus Foundation, Clearside Biomedical Inc., Chengdu Pharmaceuticals, Opthea Ltd, Genentech, and Apellis Pharmaceuticals.

VBS 8: Virtual Series returns with Part Three -VBX-Surgeons, featuring debates on diabetic retinopathy management and drainage during retinal detachment repair, quick-htting Lightning Rounds, a dry AMD trial update, and wellness. Join us for another session of world-class talks, dynamic panel discussions, and lively audience participation on Wednesday, July 29 (8:30 - 10p EST). Registration is FREE. https://us02web.zoom.us/webinar/register/WN_b42pOwhFSxOZCBpiXjPEhA

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.